| 1996 |
- First successful artificial heart transplant in Asia.
|
 |
| |
|
| 1997 |
- Successful surgery for the oldest hepatoma patient (93yrs) ever recorded
in the medical literature.
|
| |
|
| 1998 |
- First successful cardiac cryosusrgery in the world.
|
| |
|
| 1999 |
- First in Asia to perform stereotactic microeletrode pallidotomy for
Parkinsonism
|
| |
|
| 2000 |
- First successful heart transplantation for the youngest patient (6 months
of age) in Asia.
|
| |
| 2001 |
- Created a unique treatment modality for advanced nasopharyngeal carcinoma
(NPC) with the highest cure rare in the world, performed by Drs. Ko, Hong,
and Ru (KHR).
- Application of Cutaneous Epidermal Cell to Treat Limbal Insufficiency.
|
| |
| 2003 |
- The first patient with server acute respiratory syndrome (SARS) in Taiwan
was recognized. Cared for most SARS patients.
- Successfully performed the first mini-allogeneic transplantation treatment
of nasopharyngeal carcinoma in the world.
|
| |
| 2004 |
- Conducted the world’s largest clinical trial of HPV vaccine for cervical
cancer.
|
| |
| 2005 |
- The first cross match positive live donor renal transplantation
accomplished in Asia.
|
| |
| 2006 |
- Performed first Potassium-titanyl-phosphate Laser Nasopharyngectomy with
nasopharyngoscopic guide for recurrent nasopharyngeal carcinoma.
- World’s first pharmacogenomic testing to predict interferon therapy
efficacy for treating chronic hepatitis C patients.
|
|
|
| 2007 |
- Performed the first successful Bicaval Heart Transplantation to treat both
superior vena cava syndrome and severe heart failure in Taiwan.
- Cooperated with Viet Duc hospital to perform the first living donor liver
transplant in Vietnam. It was a great milestone and medical achievement in
Vietnam.
|
| |
| 2008 |
- Successfully saved a drowning victim using Extra Corporeal Membrane
Oxygenation (ECMO) for 117 days, the longest record of ECMO use in the
world.
- By applying genetic screening techniques to the in-vitro fertilization
process, NTUH successfully helped a couple to have a healthy and HLA-matched
baby girl. The baby’s cord blood was collect for cord blood transplantation.
NTUH has conducted the Asia’s first cord blood transplant from a “rescue
baby” to a boy with β-Thalassaemia Major.
- Performed the first successful heart transplantation with the recipient
under ECMO for 16 days without a heart. The Genetic Medicine Team at
National Taiwan University Hospital has developed the world’s first newborn
screening program for Pompe disease.
|
| |
| 2009 |
- Successfully synthesized Metaiodobenzylguanidine (MIBG) scintigraphy,
radiolabeled with iodine-123; independently produced the FDG, radiolabeled
with fluorine-18 (F-18), and the F-DOPA, to detect and diagnose
neuroblastoma.
- Designed and developed a new surgical technique, single-hole
laparoscopy-assisted gastrectomy, for the treatment of early gastric cancer.
With this new method, the wound is only 2 cm in size. The patients can
benefit with less pain, better outcome and earlier recovery.
- Performed the first case in Asia using “Vagal Nerve Stimulator” to treat a
young child with intractable epilepsy. This treatment can benefit those
patients with intractable epilepsy who cannot be treated by intracranial
surgery, antiepileptic medicine or ketogenic diet.
- Announced successful treatment of recurrent corneal erosions with Nd:YAG
laser. The success rate is 85%. The research result was published in
“Ophthalmology” and was reported by “Eye World” magazine.
- Department of Pediatrics, Department of Medical Genetics and Department of
Surgery of NTUH worked as a team to provide an integrated treatment for an
infant from Thailand born with Citrullinemia. This case has provided a
building block for future international medical treatment for critical
diseases.
- Successfully performed Asia’s first case of Deep brain stimulation (DBS)
to treat Parkinson disease. Compared with traditional surgery, this
procedure can reduce operating time by three to four hours and is able to
increase the accuracy rates by 46%.
- Discovered a medicine for treating Niemann-Pick disease Type C. The new
treatment successfully inhibits deterioration of the disease and improves
the patients’ quality of life. European Union has approved this medicine for
the treatment of Niemann-Pick disease Type C.
- Introduced a groundbreaking technology in the diagnosis of Leukemia. It
combines regular dynamic contrast-enhanced magnetic resonance imaging
(DCE-MRI) with an innovative analysis algorithm to select high-risk
phenotype AML patients for tailored anti-angiogenic therapy, monitor
treatment response and evaluate the outcome. The research result has been
presented in Blood.
|
| |
| 2010 |
- The“Center for Parkinson and Movement Disorders” was certified for the “Symbol of National Quality.
- The advanced laparoscopic surgical team successfully completed a single-incision , minimally invasive laparoscopic appendectomy .It was the nation’s first case.
- The successful treatment of a woodchuck with hepatoma using a mixture of multiple gene therapy and a research paper was published in the “Proceedings of the National Academy of Sciences of the United States of America (PNAS)”.
- The Successful heart transplantation in a positive cross-match patient.
|